Cabaletta Bio
Price & Volume
Stats
See moreOpen | $3.76 |
Previous Close | $3.72 |
Day Range | $3.75-$4.08 |
52W Range | $1.26-$4.23 |
Market Cap | $595.1M |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.79 |
News
See moreYahoo Finance • 24 days ago
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
Yahoo Finance • 30 days ago
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
Yahoo Finance • last month
Cellares’ Cell Shuttle used in first patient infusions of Cabaletta Bio CAR T therapy
Yahoo Finance • 4 months ago
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
About
CEO | Dr. Steven A. Nichtberger M.D. |
Address | 2929 Arch Street, Philadelphia, PA, United States, 19104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 154 |